DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 7000 participants.
Also called NCT07795398
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 7,000 participants
- Registry
-
NCT07795398 -
2026-525442-30-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT07795398. Randomized; no masking; primary purpose treatment. Start 2026-09-30 (actual); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
- Acronym
- DAN-RELEASE
- Condition
- Ischemic Heart Disease
- Condition
- Ischemic Heart Disease Chronic
- Condition
- Chronic Coronary Syndrome
- Condition
- Myocardial Infarction
- Condition
- Percutaneous Coronary Intervention
- Condition
- Coronary Artery Bypass Graft
- Condition
- Aspirin
- Condition
- Aspirin Causing Adverse Effects in Therapeutic Use
- Condition
- Non-inferiority Trial
- Intervention (Drug)
- Continuation of daily low-dose Aspirin
- Intervention (Drug)
- Discontinuation of daily low-dose Aspirin
- Lead sponsor
- Odense University Hospital
- Collaborator
- University Hospital Bispebjerg and Frederiksberg
Record details
- Record id
cardio:ct-nct07795398- Content hash
61dfbb40fa3a7162e6b430c0f6f5d5fe45b23e6285e540e7513a4028cf767bb6